Champlain Investment Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Champlain Investment Partners's VCYT Position: Q2 2026 in Review
Champlain Investment Partners reduced its Veracyte (VCYT) stake by 37% in Q2 2026, selling an estimated $4.36M and leaving 177,930 shares worth $10.4M. The position accounts for 0.27% of the portfolio, ranked #121.
Champlain Investment Partners first reported a position in VCYT in Q1 2021 and has held it in 20 quarters since. The position peaked at $86.2M in Q3 2024. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Champlain Investment Partners held 177,930 shares of Veracyte worth $10.4M as of Q2 2026.
- Champlain Investment Partners sold 103,993 Veracyte shares in Q2 2026, an estimated $4.36M.
- Veracyte made up 0.27% of Champlain Investment Partners's portfolio in Q2 2026, its #121 holding.
- Champlain Investment Partners first reported a position in Veracyte in Q1 2021 and has held it in 20 quarters since.
- Champlain Investment Partners's Veracyte position peaked at $86.2M in Q3 2024.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.